SK-PHARMA REVITALIZING THE PHARMACEUTICAL SPHERE
Our Goals
SK-Pharma is a global pharmaceutical company focusing on early genericism
of valuable medicinal products worldwide. Our mission is to improve wellbeing
by allowing accessible medicines to all patients in needs.
At SK-Pharma our core business is to launch complex and non-infringing
generic medicines in the markets of interest, such as Israel & Palestinian
Authority, CIS, Balkans and Latin America.
Additionally, our company provide access to a Patient Support Program for
rare and unique products as well as providing products that are difficult to
obtain to thousands of patients globally.
Our team also works closely with worldwide drug shortages using our special
capabilities to foresee shortages. Utilizing our unique smart machine and data
management tool ‘GDS’, enables our team at SK-Pharma the ability, to apply
cutting edge technologies, to offer smart and timely solutions for drug
shortages and supply issues.
Our group is divided into different departments; elite business development,
business intelligence, IP & litigation, data science and creative regulatory
affairs. Together our teams synergistically engage to support our mission of
leading the industry by providing unique, practical and realistic solutions.


Our Focused Agenda
To be a leading “First-to-Market” generic player. We aim to achieve this
through; strategic alliances, product development, licensing and
manufacturing of specialty pharmaceuticals. Our company goal is to achieve
80% of our developments as “First-to-Market” products.
We are striving to improve and secure our product portfolio and market of
operations based on ‘Blue Ocean Strategy’, where low competition and high
growth is expected. Our laser focus on early launch opportunities is our
leading catalyst for success within our stable business environment. Our
innovative technological advances allow us to be “one step ahead” of our
competitors allowing for our fast and efficient business.

Join our mission
We export international pharmaceutical products to pharmacies, wholesalers
and manufacturers in over 60 countries, such as EU, USA, Russia and Latin
America. We acquire our medicines exclusively from selected suppliers and
operate under strict compliance with specific regulatory bodies, such as the
Israel Ministry of Health.
Contact us
for more information.


Meet our CEO
Shlomo is the Founder and CEO of SK-Pharma Group, a global pharmaceutical company that manufactures, sells, and markets generic, specialty pharma, hybrid generics and biosimilar pharmaceutical products in over 15 countries.

Latest news and
initiatives
Follow news and programs from SK-Pharma
Worldwide offices
Our company has representative offices in 7 countries and as well as strategic partners in more than 50 countries across the globe.
Our company’s growth is driven by global generics.










